UPI MDR: 0.4% Fee on Merchant Payments Above ₹2,000

UPI MDR: 0.4% Fee on Merchant...

India’s digital payments landscape is set for a change as the National...

BDO Australia Appoints Daniel Rae as Partner

BDO Australia has appointed Daniel Rae as Partner in its International Trade and Customs team in Sydney, strengthening the firm’s advisory capabilities...

Primus Partners Marks Seven Years of Consulting Growth

Primus Partners, an India-focused management consulting firm, has marked seven years of operations, highlighting its growth from a homegrown consulting firm...

Karnataka CM Shivakumar Highlights Democracy

Karnataka Chief Minister D.K. Shivakumar highlighted the importance of democratic values, dignity and citizen participation on September 15 - 2026, as India observed the International Day of Democracy.

Vista Equity Explores Finastra Sale

Private equity firm Vista Equity Partners is exploring strategic options for Finastra, a London-headquartered financial software provider serving banks and other financial institutions, according to people familiar with the matter....

Analysys Mason Appoints Ivan Segrt as Partner

Analysys Mason Appoints Ivan Segrt as Partner

Analysys Mason has appointed Ivan Segrt as a Partner in its Transformation...

Oil Surge Adds Pressure on Indian Rupee

Oil Surge Adds Pressure on Indian Rupee

India’s rupee came under renewed pressure on September 11, 2026, as a sharp...

Hong Kong Revival Drives Demand for Advisory Talent

Hong Kong Revival Drives Demand for Advisory Talent

Hong Kong is seeing a renewed flow of financial professionals as a strong IPO...

Weil M&A Dealmaker Michael Aiello Joins Cravath

Weil, Gotshal & Manges is set to lose one of its most prominent M&A lawyers, with Michael J. Aiello, who has led the firm’s more than 600-person corporate practice, preparing to join Cravath, Swaine & Moore alongside five other M&A-focused....

Novartis Shareholder Demands Board Shake-Up Over M&A

Swiss pharmaceutical giant Novartis is facing growing shareholder pressure over its acquisition strategy after a series of setbacks involving drugs obtained through deals.

Magazine Edition






🍪 Do you like Cookies?

We use cookies to ensure you get the best experience on our website. Read more...